Advancing Kidney Care With Solidified Evidence - SphingoTec Presents PenKid at AKI & CRRT Course in Vicenza

June 18, 2024 4:20 AM

Diagnostics company SphingoTec GmbH ("SphingoTec") introduced together with Boditech Med Inc. (Boditech) at the 42nd AKI & CRRT Course in Vicenza the innovative kidney function biomarker penKid developed by SphingoTec and licensed to Boditech. They highlighted the benefits of penKid on the AFIAS platform, emphasizing its promise in enhancing kidney function assessment. With the AFIAS penKid® test, the companies will focus on market development,...

Read more

Former Facebook CEO (ANZ) Stephen Scheeler Announced as Keynote Speaker for Better Outcomes

June 17, 2024 7:00 PM

AlayaCare, a leading Home and Residential Care software provider, today announces Stephen Scheeler - former CEO of Facebook ANZ, renowned business leader, and digital innovation expert - as the keynote speaker at Better Outcomes 2024. Better Outcomes is AlayaCare's flagship user conference that will be held on 3 September in Sydney. Scheeler brings vast experience as a leader who drove Facebook's unprecedented rise in Australia and New...

Read more

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

June 17, 2024 5:00 PM

Revenues increased 14% in Q4 2024 compared to Q4 2023Gross profit margin improved 3% in FY 2024 compared to FY 2023Net loss improved 18% in Q4 2024 compared to Q4 2023, and 6% in FY 2024 compared to FY 2023BOULDER, CO / ACCESSWIRE / June 17, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA),a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of...

Read more

Avinger Announces Closing of up to $24 Million Public Offering

June 17, 2024 4:05 PM

$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series WarrantsREDWOOD CITY, CA / ACCESSWIRE / June 17, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the closing its...

Read more

Valeo Pharma Hits Record 2nd Quarter Revenue as Demand for Asthma Products Continues to Rise

June 17, 2024 2:45 PM

Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million recorded in the same quarter of 2023. This represents a growth of 4%. The revenue increase was primarily driven by a boost in sales due to promotional activities in the...

Read more

Owned Reputation Unveils its O.R. Blueprints Platform for Medical Practices

June 17, 2024 2:00 PM

Owned Reputation (O.R.), a consulting firm that delivers do-it-yourself (DIY) promotional tools, resources, and guidance for those who are not experts in marketing communications, today unveiled its O.R. Blueprints platform for medical practices. The digital platform provides step-by-step, expert instruction to medical practice owners, administrators, clinicians, and staff members so they can enhance brand recognition, attract new patients,...

Read more

When 'Women Shine', Communities Prosper

June 17, 2024 12:30 PM

NORTHAMPTON, MA / ACCESSWIRE / June 17, 2024 / In January, acclaimed photographer and passionate member of CARE's Global Advisory Council, Nigel Barker visited Sierra Leone with CARE and met Mabinty Thullah, a 35-year-old mother of three, businesswoman, farmer, and teacher in Sierra Leone. Mabinty is one of 5,000 people reached by CARE's Women Shine economic empowerment project over the last two years, developed with support from Tiffany &...

Read more

FindMyClinicalTrial Inc. Collaborates With Mayo Clinic on Clinical Trial Software

June 17, 2024 12:10 PM

WASHINGTON, DC / ACCESSWIRE / June 17, 2024 / FindMyClinicalTrial Inc. (FMCT), a digital health startup company building patient engagement and recruitment solutions for clinical trials, today announced a know-how agreement with Mayo Clinic to continue and finalize the development of FMCT's clinical trial platforms for patients, health centers, and research sites.FMCT Logo FindMyClinicalTrial Logo Clinical trials are crucial for advancing...

Read more

LFTD Partners Inc. Applauds Florida Governor DeSantis for Veto of Jobs-Destroying Hemp Bill

June 17, 2024 10:50 AM

JACKSONVILLE, FL / ACCESSWIRE / June 17, 2024 / LFTD Partners Inc. (OTCQB:LIFD), the corporate parent of leading hemp-derived and other consumer products maker Lifted Made, issued the following open letter applauding Florida Governor Ron DeSantis for his June 7, 2024 veto of Senate Bill 1698, which if it had become law would have caused the shutdown of an estimated 5,000 businesses, the termination of employment of 64,000 employees earning $7.3...

Read more

KindlyMD(TM) is Proudly Contracted with Blue Cross Blue Shield Under Utah’s Top Insurance Payors

June 17, 2024 9:00 AM

KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it has received additional credentialing and is now proudly contracted with Blue Cross Blue Shield under Utah's top insurance payors.The Company recently announced it became one of the...

Read more

Nava Health Signs Lease for Marlton, New Jersey Location

June 17, 2024 8:30 AM

Nava Health, a leader in longevity, integrative, and functional medicine, is proud to announce its expansion to Marlton, New Jersey. The new Nava Center will be located at The Promenade at Sagemore, 500 Route 73 South in Marlton, New Jersey. This marks the Company's second confirmed location in the state, following its announcement of a new center in Montvale with a third planned in Madison later this year. This expansion brings Nava Health's...

Read more

Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients

June 17, 2024 8:20 AM

NAPLES, FL / ACCESSWIRE / June 17, 2024 / In a phenomenal year marked by over +180% gains in its stock price, Cardiol Therapeutics Inc. (NASDAQ:CRDL)(TSX:CRDL) added another feather to its cap last week with the announcement of its Phase II MAvERIC-Pilot study topline results.The Canadian biotechnology company has captured investors' attention this year with significant milestones achieved, including the advancement of two simultaneous Phase II...

Read more

AlayaCare Residential Launches Financial Management for Retirement Living

June 16, 2024 7:00 PM

AlayaCare Residential, an All-In-One cloud solution that's reimagining care across Australia and New Zealand, today announces the launch of Financial Management for Retirement Living. This new feature, an update to AlayaCare Residential's existing Financial Management component, cements AlayaCare Residential as an All-In-One cloud solution facilitating an end-to-end continuum of care. This significant milestone enables organisations to track...

Read more

The WISH Clinic Partnering With Clara Care to Bring Specialized Wound Care Directly to Patients in the Convenience of Their Homes

June 15, 2024 12:00 PM

DENVER, CO / ACCESSWIRE / June 15, 2024 / Each year over 120,000 Coloradans are affected by debilitating chronic wounds, negatively affecting their quality of life and presenting significant health-related risks. Recognizing that access to specialized wound care is challenging for many, and that telehealth can play a major role in improving the state of care for thousands of Coloradans, The WISH Clinic, a premier skin rejuvenation and wound care...

Read more

Marcroft Medical Launches as Premier Distributor of High-Quality Medical Equipment

June 14, 2024 10:05 PM

Founded on principles of excellence and dedication to patient care, Marcroft Medical understands the unique challenges medical practices face today. The company is dedicated to providing Portable Ultrasound Devices that enhance the quality of patient care and ensure healthcare providers have access to the best equipment available. Key Highlights of Marcroft Medical:Wide Range of Products: Offering a broad spectrum of medical equipment,...

Read more

Reminder Notice of Annual General and Special Meeting for Shareholders of Theralase(R)

June 14, 2024 4:45 PM

TORONTO, ON / ACCESSWIRE / April 14, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formulations intended for the safe and effective destruction of various cancers, bacteria and viruses, is providing a reminder notice for its Annual General and Special...

Read more

Intellipharmaceutics Announces Downgrade to OTC Expert Market

June 14, 2024 4:36 PM

Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI.H) ("Intellipharmaceutics" or the "Company"), announced today that its common stock, currently traded on the OTCQB market, is expected to be downgraded to the OTC Expert Market on June 17, 2024 as a result of the Company not filing its Form 20-F for the year ended11/30/2023.Quotes in the Expert Market are "Unsolicited Only." This means broker-dealers may use the Expert Market to...

Read more

Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024

June 14, 2024 4:30 PM

DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the three and six months ended April 30, 2024 were approximately $2.4 and...

Read more

CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement

June 14, 2024 3:11 PM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it has entered into securities purchase agreements with health-care focused institutional investors for the purchase and sale of 366,000 shares of common stock (or common stock equivalents in lieu thereof) in a...

Read more

Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences

June 14, 2024 2:30 PM

LAVAL, QC / ACCESSWIRE / June 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, recently presented at two global healthcare conferences. Bausch Health's gastroenterology (GI) business, Salix Pharmaceuticals presented data from its Amiselimod clinical trials at Digestive Disease Week (DDW) 2024 during the IMIBD Late...

Read more